Literature DB >> 9862843

Effects of chronic ethanol administration on rat liver proteasome activities: relationship with oxidative stress.

V Fataccioli1, E Andraud, M Gentil, S W French, H Rouach.   

Abstract

We previously reported that ethanol elicits an increased protein oxidation in the liver of rats receiving chronic ethanol by continuous intragastric infusion (Tsukamoto-French method). This accumulation of oxidized proteins could result from a decrease in the cytosolic proteolysis, related specifically to alkaline protease and its major components, the proteasomes. Because several studies suggest that intracellular proteolysis depends on the severity of oxidative stress, we investigated the cytosolic proteolytic activity under two chronic ethanol treatment paradigms associated with varying degrees of oxidative stress. For 4 weeks, male rats received chronic ethanol by continuous intragastric infusion or by oral administration (10% ethanol ad libitum as sole drinking fluid). A significant decrease was evident for alkaline protease activity as well as for sodium dodecyl sulfate (SDS)-activated latent 20S proteasome (chymotrypsine-like [ChT-L] and peptidylglutamyl peptide hydrolase [PGPH] activities) in the liver of rats receiving ethanol by continuous intragastric infusion. Free radical production and related processes appeared to be contributing events in proteolysis inhibition, because phenethyl isothiocyanate (PIC), an inhibitor of cytochrome P4502E1 (CYP2E1), reduced the inhibition of the ethanol-related ChT-L activity. Moreover, the lipid peroxidation level was inversely correlated with ChT-L activity. In contrast, no such changes were observed in ChT-L and PGPH activities or in cellular free radical targets following the oral ad libitum consumption of 10% ethanol. It appears, thus, that only the alcohol treatment paradigm associated with an overt oxidative stress produced a significant inhibition of the proteasome activity. The mechanisms of proteasome inhibition could involve the formation of an endogenous inhibitor such as protein aggregates or aldehyde-derivative peptides. Whatever the mechanism, the inhibition of cytosolic proteolysis and the subsequent accumulation of damaged proteins may be involved in the oxidatively challenged alcoholic livers and play a pathogenic role in experimental alcoholic liver disease.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9862843     DOI: 10.1002/hep.510290106

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  20 in total

Review 1.  Implication of altered proteasome function in alcoholic liver injury.

Authors:  Natalia A Osna; Terrence-M Donohue
Journal:  World J Gastroenterol       Date:  2007-10-07       Impact factor: 5.742

2.  Alcoholic liver disease - Hepatocellular carcinoma transformation.

Authors:  Samuel W French; James Lee; Jim Zhong; Timothy R Morgan; Virgil Buslon; William Lungo; Barbara A French
Journal:  J Gastrointest Oncol       Date:  2012-09

Review 3.  Alcoholic liver disease.

Authors:  K Walsh; G Alexander
Journal:  Postgrad Med J       Date:  2000-05       Impact factor: 2.401

Review 4.  Effects of ethanol on the proteasome interacting proteins.

Authors:  Fawzia Bardag-Gorce
Journal:  World J Gastroenterol       Date:  2010-03-21       Impact factor: 5.742

5.  p62 Is a common component of cytoplasmic inclusions in protein aggregation diseases.

Authors:  Kurt Zatloukal; Cornelia Stumptner; Andrea Fuchsbichler; Hans Heid; Martina Schnoelzer; Lukas Kenner; Reinhold Kleinert; Marco Prinz; Adriano Aguzzi; Helmut Denk
Journal:  Am J Pathol       Date:  2002-01       Impact factor: 4.307

6.  Chronic ethanol feeding affects proteasome-interacting proteins.

Authors:  Marie-Pierre Bousquet-Dubouch; Sheila Nguen; David Bouyssié; Odile Burlet-Schiltz; Samuel W French; Bernard Monsarrat; Fawzia Bardag-Gorce
Journal:  Proteomics       Date:  2009-07       Impact factor: 3.984

7.  Non-invasive index of liver fibrosis induced by alcohol, thioacetamide and Schistosomal infection in mice.

Authors:  Mohamed H Hessien; Ismaiel M El-Sharkawi; Ahmed A El-Barbary; Doha M El-Beltagy; Ned Snyder
Journal:  BMC Gastroenterol       Date:  2010-06-01       Impact factor: 3.067

8.  Protective effect of phosphatidylcholine on restoration of ethanol-injured hepatocytes related with caveolin-1.

Authors:  Yuan Zhang; Wei Zou; Fenggong Cui; Nan Wang; Dongyan Zhang; Yuying Cui; Peng Liu; Jing Liu
Journal:  J Membr Biol       Date:  2013-11-29       Impact factor: 1.843

9.  Effects of daily, light and moderate-heavy ethanol exposure on extent of hepatic injury and recovery following toxin-induced acute hepatitis in rats.

Authors:  Manna Zhang; Julia Uhanova; Ian Corbin; Charles Bernstein; Gerald Y Minuk
Journal:  Dig Dis Sci       Date:  2003-05       Impact factor: 3.199

10.  Polyenephosphatidylcholine prevents alcoholic liver disease in PPARalpha-null mice through attenuation of increases in oxidative stress.

Authors:  Wataru Okiyama; Naoki Tanaka; Tamie Nakajima; Eiji Tanaka; Kendo Kiyosawa; Frank J Gonzalez; Toshifumi Aoyama
Journal:  J Hepatol       Date:  2009-04-02       Impact factor: 25.083

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.